GLUNAC 5 MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1058309260024 -
GGREM
526124050177004 -
Código de barras
7896004790947
O que a fonte publica
- Detentor do registro
- GERMED FARMACEUTICA LTDA
- Princípios ativos
- LINAGLIPTINA
- Embalagem
- 5 MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "GLUNAC 5 MG COM REV CT BL AL AL X 30",
"holder": "GERMED FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896004790947"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526124050177004",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "45.992.062/0001-65",
"priceRegime": "Regulado",
"productName": "GLUNAC",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "205.03",
"icms-12": "232.99",
"icms-17": "247.02",
"icms-18": "250.04",
"icms-19": "253.12",
"icms-20": "256.29",
"icms-21": "259.53",
"icms-22": "262.86",
"icms-23": "266.27",
"icms-17.5": "248.52",
"icms-19.5": "254.70",
"icms-20.5": "257.90",
"icms-22.5": "264.55",
"icms-12-alc": "208.03",
"icms-17-alc": "220.56",
"icms-18-alc": "223.25",
"icms-19-alc": "226.00",
"icms-20-alc": "228.83",
"icms-21-alc": "231.72",
"icms-22-alc": "234.70",
"icms-23-alc": "237.74",
"withoutTaxes": "183.06",
"icms-17.5-alc": "221.89",
"icms-19.5-alc": "227.41",
"icms-20.5-alc": "230.27",
"icms-22.5-alc": "236.21"
},
"pisCofinsList": "Negativa",
"substanceText": "LINAGLIPTINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "275.04",
"icms-12": "312.55",
"icms-17": "331.37",
"icms-18": "335.42",
"icms-19": "339.55",
"icms-20": "343.80",
"icms-21": "348.15",
"icms-22": "352.62",
"icms-23": "357.19",
"icms-17.5": "333.38",
"icms-19.5": "341.67",
"icms-20.5": "345.96",
"icms-22.5": "354.88",
"icms-12-alc": "287.59",
"icms-17-alc": "304.91",
"icms-18-alc": "308.63",
"icms-19-alc": "312.43",
"icms-20-alc": "316.34",
"icms-21-alc": "320.34",
"icms-22-alc": "324.46",
"icms-23-alc": "328.66",
"withoutTaxes": "253.07",
"icms-17.5-alc": "306.75",
"icms-19.5-alc": "314.38",
"icms-20.5-alc": "318.33",
"icms-22.5-alc": "326.55"
},
"invalidBarcodes": [],
"activeSubstances": [
"LINAGLIPTINA"
],
"therapeuticClass": "A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1058309260024",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10N1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526124050177004"